The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

About Allurion Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss ... The Allurion Gastric Balloon is an investigational device in the United States. For more information ...

BROWNSVILLE — It was an unusually cold Saturday morning in the Rio Grande Valley but that didn't stop hundreds of people from forming a line that wound throughout the south side of the Brownsville ...

Michael W. Schwartz UW Medicine Diabetes Institute, explains how the brain can be targeted to treat obesity and diabetes ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

A new report notes that the amount of belly fat a patient has is a more useful metric for determining obesity than ...

According to a September 2024 data brief from the Centers for Disease Control and Prevention (CDC), 40.3 percent of U.S.

A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...